Role of Viruses and Other Microbes in the Pathogenesis of Type 1 Diabetes
Authors:
- 10 March 2014
- journal article
- review article
- Published by Taylor & Francis in International Reviews of Immunology
- Vol. 33 (4) , 284-295
Abstract
Type 1 diabetes is caused by an immune-mediated destruction of insulin producing beta-cells in the pancreas. The risk of the disease is determined by interactions between more than 40 different susceptibility genes and yet unidentified environmental factors. The rapidly increasing incidence indicates that these environmental agents have a significant role in the pathogenesis. Microbes have associated with both increased and decreased risk reflecting their possible role as risk or protective factors. Two main hypotheses have been proposed to explain these effects: the hygiene hypothesis suggests that microbial exposures in early childhood stimulate immunoregulatory mechanisms which control autoimmune reactions (analogy with allergy), while the triggering hypothesis suggests that specific microbes damage insulin producing cells. Certain viruses, particularly enteroviruses, are currently the main candidates for such risk microbes. Enteroviruses cause diabetes in animals and have associated with increased risk of type 1 diabetes in epidemiological studies. They have also been detected in the pancreas of diabetic patients. Possible protective effect of microbes has been studied in animal models and in epidemiological studies, where certain enteral microbes (e.g. hepatitis A virus and Helicobacter pylori) and patterns of gut microbiome have associated with low risk of type 1 diabetes. In conclusion, these microbial effects offer attractive possibilities for the development of preventive interventions for type 1 diabetes based on the elimination of triggering agents (e.g. enterovirus vaccines) or use of protective microbes as probiotics.Keywords
This publication has 88 references indexed in Scilit:
- Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoringBMC Neurology, 2013
- Quantitative Genomic and Antigenomic Enterovirus RNA Detection in Explanted Heart Tissue Samples from Patients with End-Stage Idiopathic Dilated CardiomyopathyJournal of Clinical Microbiology, 2012
- Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetesClinical and Experimental Immunology, 2012
- Virus Infections in Type 1 DiabetesCold Spring Harbor Perspectives in Medicine, 2011
- Toward defining the autoimmune microbiome for type 1 diabetesThe ISME Journal, 2010
- Viral Persistence and Chronic Immunopathology in the Adult Central Nervous System following Coxsackievirus Infection during the Neonatal PeriodJournal of Virology, 2009
- Identification of Loss of Function Mutations in Human Genes Encoding RIG-I and MDA5Journal of Biological Chemistry, 2009
- Innate immunity and intestinal microbiota in the development of Type 1 diabetesNature, 2008
- Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patientsProceedings of the National Academy of Sciences, 2007
- Allergic sensitization and microbial load – a comparison between Finland and Russian KareliaClinical and Experimental Immunology, 2007